Institutional shares held 66.2 Million
415K calls
275K puts
Total value of holdings $15B
$93.8M calls
$62.1M puts
Market Cap $16.7B
74,033,000 Shares Out.
Institutional ownership 89.35%
# of Institutions 805


Latest Institutional Activity in WST

Top Purchases

Q2 2025
Burt Wealth Advisors Shares Held: 19.1K ($4.31M)
Q2 2025
Rockland Trust CO Shares Held: 78K ($17.6M)
Q2 2025
First National Bank Sioux Falls Shares Held: 4.73K ($1.07M)
Q2 2025
Salem Investment Counselors Inc Shares Held: 2.55K ($577K)
Q2 2025
Baader Bank Aktiengesellschaft Shares Held: 1.77K ($400K)

Top Sells

Q2 2025
Gateway Investment Advisers LLC Shares Held: 21.7K ($4.9M)
Q2 2025
Seilern Investment Management LTD Shares Held: 432K ($97.6M)
Q2 2025
Wealth Enhancement Advisory Services, LLC Shares Held: 26.6K ($6.01M)
Q2 2025
Trust Point Inc. Shares Held: 2.01K ($453K)
Q2 2025
Wedmont Private Capital Shares Held: 1.32K ($299K)

About WST

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. It serves pharmaceutical, diagnostic, and medical device companies. The company distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. West Pharmaceutical Services, Inc. was incorporated in 1923 and is headquartered in Exton, Pennsylvania.


Insider Transactions at WST

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
54.7K Shares
From 19 Insiders
Grant, award, or other acquisition 12.2K shares
Exercise of conversion of derivative security 42.4K shares
Sell / Disposition
33.9K Shares
From 10 Insiders
Payment of exercise price or tax liability 1.46K shares
Open market or private sale 32.5K shares

Track Institutional and Insider Activities on WST

Follow WEST PHARMACEUTICAL SERVICES INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells WST shares.

Notify only if

Insider Trading

Get notified when an West Pharmaceutical Services Inc insider buys or sells WST shares.

Notify only if

News

Receive news related to WEST PHARMACEUTICAL SERVICES INC

Track Activities on WST